Trial
NCT03469011
A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
AHS Cancer Control Alberta
Collaborators
Alberta Cancer Foundation
Condition
Papillary Thyroid Cancer
Intervention
Imatinib Oral Tablet
Why stopped
Lack of Accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-27